RICHMOND, Va., Oct. 31, 2001 (PRIMEZONE) -- Informed Investors' 5th annual Cancer Stocks Forum on Tuesday, Dec. 4, 2001 offers investors excellent insight into several leading companies pursuing the ongoing battle against cancers of all kinds.
The virtual Forum is accessible over the Internet via www.informedinvestors.com from 8:30 a.m. EST to 1 p.m., and will also be archived on www.vcall.com and www.investorconference.com. There is no cost to investors. The keynote speaker is Alan Auerbach, Vice President/Research Analyst at Wells Fargo Van Kasper. Auerbach specializes in the biotechnology and biomedical sectors.
Among the representative list of companies participating is AEterna Laboratories (Nasdaq:AELA). The Quebec City-based company is currently involved in the final phase of clinical trials for Neovastat, its shark cartilage-based treatment for lung and kidney cancer. AEterna hopes to bring the drug to market in 2002.
Another Canada-based company, Biomira (Nasdaq:BIOM) is a biotechnology company specializing in the development of innovative therapeutic approaches to cancer management. In addition to completion of enrollment of the multinational Phase III trial with THERATOPE(r) vaccine (which is formulated with Corixa's ENHANZYN(tm) adjuvant), Biomira is developing a portfolio of complementary vaccine candidates, including BLP25 vaccine for NSCLC, now in Phase IIb trials.
The Seattle-based company, Targeted Genetics (Nasdaq:TGEN), is also scheduled to present. It develops gene therapy products for the treatment of acquired and inherited diseases. TGEN's clinical product development programs target cystic fibrosis and cancer. The company also has a promising pipeline of product candidates focused on hemophilia A, arthritis, cancer, lysosomal storage diseases, cardiovascular disease and AIDS prophylaxis. TGEN has a broad platform of gene delivery technologies and, through its majority-owned subsidiary, CellExSys, Inc., a promising body of technology for cellular therapy.
The other companies presenting at the Forum include: Aastrom Biosciences, Dendreon Corp., Genentech, Genzyme Molecular Oncology, and Onyx Pharmaceuticals.
Senior executives will review their company's current prospects and overview their business strategies in the same fashion they do for institutional investors. The segments are approximately 30 minutes each and include PowerPoint presentations. Also, investors are invited to email questions to executives.
Informed Investors is the leading producer of online and offline industry-specific investment conferences for individual investors and a member of the World Investor Link family of companies serving self-reliant investors.
About World Investor Link: Since 1992, World Investor Link (www.worldinvestorlink.com) has opened information channels from public companies to potential investors. This year, World Investor Link will make more than 5 million investor introductions to over 4,600 corporate clients worldwide through services including The Annual Reports Service, The Fund Info Service, Vcall (www.vcall.com), Investor Conference (www.investorconference.com), and Informed Investors Forums (www.informedinvestors.com). World Investor Links' array of products and services enables companies to comply with regulation fair-disclosure requirements by providing investors free access to onsite and webcast investor events and company financial reports. Mutual funds and companies get visibility with investors at the point investors are making decisions through World Investor Link's relationships with over 160 of the leading financial media channels including The Wall Street Journal, Financial Times, Barron's and Yahoo!Finance. World Investor Link, Inc., a wholly owned subsidiary of WILink.com plc (WLK on The London Stock Exchange) began operations in Richmond, Va., in 1993.